Literature DB >> 15544801

Highly ordered supra-molecular organization of the mycobacterial lipoarabinomannans in solution. Evidence of a relationship between supra-molecular organization and biological activity.

Michel Rivière1, André Moisand, André Lopez, Germain Puzo.   

Abstract

The complex mycobacterial mannosylated lipoarabinomannans (ManLAMs) are currently considered to be the major virulence factors of the pathogenic Mycobacterium tuberculosis. The recognition and the interaction of ManLAMs with immune system receptors have been shown to promote M.tuberculosis phagocytosis but also to down-regulate the bactericidal immune response of the host in favor of the survival of the pathogenic bacilli. To date these original biological activities were mainly associated to the presence of mannose residues capping the non-reducing ends of the ramified polysaccharide moiety of these complex lipoglycans. However, we demonstrated recently that the molecular recognition of ManLAM terminal mannose units by human pulmonary surfactant protein A (hSP-A) carbohydrate recognition domains depends on the presence of the lipid moiety of the ManLAMs as proposed by Sidobre et al. in 2002. Thus, we investigated the putative role of the ManLAM aglycon moiety. The data presented here, indicate that the hydrophobic aglycon part of ManLAM is associated to a characteristic concentration-dependent supra-molecular organization of these complex molecules. Furthermore, we observed that the deacylated ManLAMs or the lipid-free mannosylated arabinomannans, which do not exhibit characteristic ManLAM activities, do not display this supra-molecular organization. These observations strongly suggest that the ManLAMs immunomodulatory activities might be associated to their particular organization. Finally, the determination of the critical micellar concentration of ManLAMs obviously supports the notion that this supra-molecular organization may be responsible for the specific biological activities of these complex molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544801     DOI: 10.1016/j.jmb.2004.09.092

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

1.  The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface.

Authors:  Sylvain Pitarque; Gérald Larrouy-Maumus; Bruno Payré; Mary Jackson; Germain Puzo; Jérôme Nigou
Journal:  Tuberculosis (Edinb)       Date:  2008-06-09       Impact factor: 3.131

2.  Trehalose 6,6'-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice.

Authors:  Robert L Hunter; Margaret Olsen; Chinnaswamy Jagannath; Jeffrey K Actor
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

3.  Carbohydrate-dependent binding of langerin to SodC, a cell wall glycoprotein of Mycobacterium leprae.

Authors:  Hee Jin Kim; Patrick J Brennan; Darragh Heaslip; Mark C Udey; Robert L Modlin; John T Belisle
Journal:  J Bacteriol       Date:  2014-11-24       Impact factor: 3.490

4.  Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.

Authors:  Supriya Shukla; Edward T Richardson; Michael G Drage; W Henry Boom; Clifford V Harding
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

5.  Mannodendrimers prevent acute lung inflammation by inhibiting neutrophil recruitment.

Authors:  Emilyne Blattes; Alain Vercellone; Hélène Eutamène; Cédric-Olivier Turrin; Vassilia Théodorou; Jean-Pierre Majoral; Anne-Marie Caminade; Jacques Prandi; Jérôme Nigou; Germain Puzo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

6.  A Mycobacterium tuberculosis-derived lipid inhibits membrane fusion by modulating lipid membrane domains.

Authors:  Eri Hayakawa; Fuyuki Tokumasu; Glenn A Nardone; Albert J Jin; Vince A Hackley; James A Dvorak
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

7.  Mycobacterial PIMs inhibit host inflammatory responses through CD14-dependent and CD14-independent mechanisms.

Authors:  Nathalie Court; Stéphanie Rose; Marie-Laure Bourigault; Sophie Front; Olivier R Martin; Jennifer K Dowling; Elaine F Kenny; Luke O'Neill; François Erard; Valerie F J Quesniaux
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

Review 8.  Manipulation of the endocytic pathway and phagocyte functions by Mycobacterium tuberculosis lipoarabinomannan.

Authors:  Isabelle Vergne; Martine Gilleron; Jérôme Nigou
Journal:  Front Cell Infect Microbiol       Date:  2015-01-12       Impact factor: 5.293

9.  Playing hide-and-seek with host macrophages through the use of mycobacterial cell envelope phthiocerol dimycocerosates and phenolic glycolipids.

Authors:  Ainhoa Arbues; GeanCarlo Lugo-Villarino; Olivier Neyrolles; Christophe Guilhot; Catherine Astarie-Dequeker
Journal:  Front Cell Infect Microbiol       Date:  2014-12-09       Impact factor: 5.293

10.  Mycobacterium avium subsp. paratuberculosis (Map) Fatty Acids Profile Is Strain-Dependent and Changes Upon Host Macrophages Infection.

Authors:  Marta Alonso-Hearn; Naiara Abendaño; Maria A Ruvira; Rosa Aznar; Mariana Landin; Ramon A Juste
Journal:  Front Cell Infect Microbiol       Date:  2017-03-21       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.